Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial

Ildiko Lingvay, Andrei Mircea Catarig, Juan P. Frias, Harish Kumar, Nanna L. Lausvig, Carel W. le Roux, Desirée Thielke, Adie Viljoen, Rory J. McCrimmon

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences